Cyndeo Wealth Partners LLC Takes $398,000 Position in Relx Plc $RELX

Key Points

• Cyndeo Wealth Partners LLC has acquired a new stake in Relx Plc, purchasing 7,331 shares valued at approximately $398,000 in Q2.
• Relx shares have recently seen fluctuations, with a current price of $44.80 and a debt-to-equity ratio of 2.55.
• The company announced a recent dividend payment, issuing $0.2634 per share, which reflects a payout ratio of 28.49%.

Cyndeo Wealth Partners LLC bought a new stake in shares of Relx Plc (NYSE:RELX - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 7,331 shares of the technology company's stock, valued at approximately $398,000.

A number of other large investors have also recently modified their holdings of the stock. Goldman Sachs Group Inc. boosted its stake in shares of Relx by 4.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 4,072,342 shares of the technology company's stock valued at $205,287,000 after purchasing an additional 173,976 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in Relx by 8.3% during the first quarter. Ameriprise Financial Inc. now owns 3,041,132 shares of the technology company's stock worth $154,129,000 after acquiring an additional 234,094 shares in the last quarter. Northern Trust Corp boosted its stake in Relx by 9.2% during the first quarter. Northern Trust Corp now owns 2,394,097 shares of the technology company's stock worth $120,686,000 after acquiring an additional 202,509 shares in the last quarter. Natixis Advisors LLC boosted its stake in Relx by 0.5% during the first quarter. Natixis Advisors LLC now owns 1,208,467 shares of the technology company's stock worth $60,919,000 after acquiring an additional 5,875 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its stake in Relx by 103.4% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 444,360 shares of the technology company's stock worth $22,400,000 after acquiring an additional 225,947 shares in the last quarter. Institutional investors own 15.02% of the company's stock.

Relx Stock Down 0.8%

Shares of Relx stock opened at $44.80 on Friday. The company has a debt-to-equity ratio of 2.55, a quick ratio of 0.42 and a current ratio of 0.47. The stock has a market capitalization of $81.87 billion, a PE ratio of 24.08, a price-to-earnings-growth ratio of 2.92 and a beta of 0.87. Relx Plc has a 52-week low of $44.19 and a 52-week high of $56.33. The company has a 50-day simple moving average of $47.22 and a two-hundred day simple moving average of $50.81.

Relx Cuts Dividend

The business also recently disclosed a semi-annual dividend, which was paid on Tuesday, September 16th. Stockholders of record on Friday, August 8th were issued a dividend of $0.2634 per share. This represents a dividend yield of 170.0%. The ex-dividend date of this dividend was Friday, August 8th. Relx's payout ratio is presently 28.49%.

Analyst Ratings Changes

RELX has been the topic of several research reports. Wall Street Zen lowered shares of Relx from a "buy" rating to a "hold" rating in a research note on Friday, September 5th. Morgan Stanley reissued an "overweight" rating on shares of Relx in a research note on Thursday, September 11th. Weiss Ratings reissued a "buy (b)" rating on shares of Relx in a research note on Wednesday. Kepler Capital Markets raised shares of Relx from a "hold" rating to a "strong-buy" rating in a report on Thursday, September 18th. Finally, Barclays reaffirmed an "overweight" rating on shares of Relx in a report on Tuesday. One analyst has rated the stock with a Strong Buy rating and five have given a Buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Buy".

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.